Veozah vs Myfembree
A side-by-side look at two women's health medications advertised on TV. Informational only — not medical advice.
Maintained by TVPills Editorial Team · Site updated November 4, 2026 (not a product-label review)
| Attribute | US Veozah | US Myfembree |
|---|---|---|
| Generic name | fezolinetant Unverified catalogue summary (Generic name) for Veozah in US; not checked against current local product information. | relugolix/estradiol/norethindrone acetate Unverified catalogue summary (Generic name) for Myfembree in US; not checked against current local product information. |
| Drug class | See official local label Unverified catalogue summary (Drug class) for Veozah in US; not checked against current local product information. | See official local label Unverified catalogue summary (Drug class) for Myfembree in US; not checked against current local product information. |
| Treats | Menopausal hot flashes Unverified catalogue summary (Treats) for Veozah in US; not checked against current local product information. | Uterine fibroids and endometriosis Unverified catalogue summary (Treats) for Myfembree in US; not checked against current local product information. |
| Category | Women's Health Unverified catalogue summary (Category) for Veozah in US; not checked against current local product information. | Women's Health Unverified catalogue summary (Category) for Myfembree in US; not checked against current local product information. |
| Manufacturer | Astellas Pharma US, Inc. (US distributor) Unverified catalogue summary (Manufacturer) for Veozah in US; not checked against current local product information. | Patheon Inc. / Sumitomo Pharma America, Inc. Unverified catalogue summary (Manufacturer) for Myfembree in US; not checked against current local product information. |
| Year approved | — Unverified catalogue summary (Year approved) for Veozah in US; not checked against current local product information. | — Unverified catalogue summary (Year approved) for Myfembree in US; not checked against current local product information. |
| Catalogue warning level | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Veozah in US; not checked against current local product information. | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Myfembree in US; not checked against current local product information. |
| Est. TV ad spend | $110M | — |
| Side effects and serious risks | — Unverified catalogue summary (Side effects and serious risks) for Veozah in US; not checked against current local product information. | — Unverified catalogue summary (Side effects and serious risks) for Myfembree in US; not checked against current local product information. |
Sources and editorial standards
Use the current DailyMed labels to verify approved uses, boxed warnings, and side effects for each medication. Label results can differ by product, strength, and formulation.
Page updated November 4, 2026; the linked resources have not necessarily been reviewed on this date.
Frequently asked questions
Is Veozah or Myfembree better?
This directory does not compare clinical effectiveness or safety. Listing Veozah and Myfembree together does not establish shared approved indications, equivalence or suitability as substitutes. Consult the correct local labels and your prescriber.
What's the difference between Veozah and Myfembree?
The table shows catalogue identification and estimated advertising information for Veozah and Myfembree, not a verified medical comparison. Medical descriptions, mechanisms and safety summaries are withheld.
Which one spends more on TV ads?
Veozah has the larger estimated TV advertising budget of the two.